| 1 |
35524809 | Meta-analysis of the associations of IMPDH and UGT1A9 polymorphisms with rejection in kidney transplant recipients taking mycophenolic acid. | 2022 May 7 |
4 |
| 2 |
33967795 | CYP3A5 and UGT1A9 Polymorphisms Influence Immunosuppressive Therapy in Pediatric Kidney Transplant Recipients. | 2021 |
1 |
| 3 |
34105062 | The Impact of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Mycophenolic Acid: Systematic Review and Meta-analysis. | 2021 Oct |
1 |
| 4 |
34390491 | Quantitative Proteomic Map of Enzymes and Transporters in the Human Kidney: Stepping Closer to Mechanistic Kidney Models to Define Local Kinetics. | 2021 Nov |
1 |
| 5 |
30636046 | Identification of specific UGT1A9-mediated glucuronidation of licoricidin in human liver microsomes. | 2019 Feb |
1 |
| 6 |
31578207 | Ginsenoside Rc Is a New Selective UGT1A9 Inhibitor in Human Liver Microsomes and Recombinant Human UGT Isoforms. | 2019 Dec |
1 |
| 7 |
27549213 | Predicting therapy response to mycophenolic acid using UGT1A9 genotyping: towards personalized medicine in atopic dermatitis. | 2017 May |
3 |
| 8 |
28613375 | Study on the association of UGT1A9 gene c.98T>C polymorphism and mycophenolic acid plasma levels in renal transplant patients. | 2017 May 31 |
2 |
| 9 |
23052409 | Polymorphisms of UGT1A9 and UGT2B7 influence the pharmacokinetics of mycophenolic acid after a single oral dose in healthy Chinese volunteers. | 2013 Apr |
2 |
| 10 |
24250661 | Impact of UGT1A9 Polymorphism on Mycophenolic Acid Pharmacokinetic Parameters in Stable Renal Transplant Patients. | 2013 Summer |
1 |
| 11 |
23131697 | UGT1A9, UGT2B7, and MRP2 genotypes can predict mycophenolic acid pharmacokinetic variability in pediatric kidney transplant recipients. | 2012 Dec |
1 |
| 12 |
21524190 | Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs. | 2011 Jul |
1 |
| 13 |
20382756 | Regioselective glucuronidation of tanshinone iia after quinone reduction: identification of human UDP-glucuronosyltransferases, species differences, and interaction potential. | 2010 Jul |
1 |
| 14 |
20431509 | Use of pharmacogenetics to optimize immunosuppressive therapy. | 2010 Jun |
1 |
| 15 |
19494809 | UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients. | 2009 Sep |
1 |
| 16 |
19715905 | The prevalence of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T and its influence on mycophenolic acid pharmacokinetics in stable renal transplant patients. | 2009 Jul-Aug |
3 |
| 17 |
18568343 | Pharmacogenetic effect of the UGT polymorphisms on mycophenolate is modified by calcineurin inhibitors. | 2008 Nov |
3 |
| 18 |
18597651 | Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers. | 2008 Jul |
2 |
| 19 |
18946804 | Influence of uridine diphosphate (UDP)-glucuronosyltransferases and ABCC2 genetic polymorphisms on the pharmacokinetics of mycophenolic acid and its metabolites in Chinese renal transplant recipients. | 2008 Nov |
1 |
| 20 |
17339869 | The impact of UGT1A8, UGT1A9, and UGT2B7 genetic polymorphisms on the pharmacokinetic profile of mycophenolic acid after a single oral dose in healthy volunteers. | 2007 Mar |
2 |
| 21 |
17529886 | Influence of UGT1A7 and UGT1A9 intronic I399 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. | 2007 Jun |
2 |
| 22 |
17924828 | C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation. | 2007 Sep |
3 |
| 23 |
15470161 | Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism. | 2005 Jan |
1 |
| 24 |
16198654 | The impact of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipients. | 2005 Oct |
2 |
| 25 |
15258099 | The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants. | 2004 Aug |
1 |
| 26 |
15284532 | Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver. | 2004 Aug |
1 |
| 27 |
10688250 | Identification of uridine diphosphate glucuronosyltransferases involved in the metabolism and clearance of mycophenolic acid. | 2000 Feb |
2 |